TRex Bio Inc. TRXB · News

website

Trex Bio, Inc. engages in the manufacture of immunotherapies for autoimmune and inflammatory disease...

Price13.59

Market Cap374.78 M

Float7.46 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

FEATURED

TRexBio Announces Closing of Initial Public Offering

SOUTH SAN FRANCISCO, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- TRex Bio, Inc. ("TRexBio") (NASDAQ:TRXB), a clinical-stage biotechnology company focused on tissue Treg biology for the discovery and development

Summary

Oct 13, 2026, 4:47 PM ·Globe Newswire

RECENT

TRexBio Announces Pricing of Initial Public Offering

SOUTH SAN FRANCISCO, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- TRex Bio, Inc. ("TRexBio") (NASDAQ:TRXB), a clinical-stage biotechnology company focused on tissue Treg biology for the discovery and development

Oct 8, 2026, 9:29 PM ·Globe Newswire